1Gao HM, Liu B, Zhang Wet al. Novel anti - inflamatory therapy for Parkinson' s disease. Trends Pharmacol Sci,2003; 24:395 -401
2Hinz B, Brune K. Cyelooxygenaxe -2 - 10 years later. J Pharm Exp Ther, 2002; 300: 367 -375
3Kurumbail RG, Stevens AM, Gierse JK et al. Structural basis for selective inhibition of cyclooxygenase -2 by anti -inflammatory agents. Nature, 1996; 384:644-648
4Chandrasekharan NV, Dai H, Roos KL et al. COX -3, a eyeoxygenase- 1 variant inhibited by aeetaminophen and other analgesie/antipyretie drugs: Cloning, structure and expression. Proc Natl Aead Sci USA, 2002; 99:13926 -13931
5Shaftel SS, Olschowka JA, Hurley SD et al. COX -3: A splice variant of cyclooxygenase - 1 in mouse neural tissue and cells. Brain Res Mol Brain Res, 2003; 119:213 -215
6Breder CI), Dewitt D, Kraig RP. Characterization of inducible cyclooxygenase in rat brain. J Comp Neural,1995; 355:296 -315
7Graham SH, Hickey RW. Cyclooxygenases in central nervous system diseases: A special role for cyclooxygenase 2 in meauronal cell death. Arch Neurol, 2003 ; 60 : 628 - 630
9Rail JM, Mach SA, Dash PK. Intrahippocampal infusion of a cyclooxygenase - 2 inhibitor attenuates memory acquisition in rats. Brain Res, 2003 ; 968 : 273 - 276
10Shaw KN, Commins S, O' Mara SM. Deficits inspatial learning and synaptic plasticity induced by the rapid and competitive broad -spectrum cyclooxygenase inhibitor ibuprofen are reversed by increasing endogenous brain- derived neurottophic factor. Eur J Neurosici, 2003 ; 17:2438 - 2446
2Botchkina GI;Geimonen E;Bilof ML.Loss of NF-kappaB activity during cerebral ischemia and TNF cytotoxicity,1999(06).
3Ge Kuang,Qin He,Yunmei Zhang,Ruichun Zhuang,Anling Xiang,Qingsong Jiang,Ying Luo,Junqing Yang,Raghu Vemuganti.Modulation of Preactivation of PPAR- β on Memory and Learning Dysfunction and Inflammatory Response in the Hippocampus in Rats Exposed to Global Cerebral Ischemia/Reperfusion[J]. <journal-title>PPAR Research . 2012
4Vinay Tergaonkar.NFκB pathway: A good signaling paradigm and therapeutic target[J]. International Journal of Biochemistry and Cell Biology . 2006 (10)
5AnttiNurmi,NinaVartiainen,ReaPihlaja,GundarsGoldsteins,JuhaYrj?nheikki,JariKoistinaho.Pyrrolidine dithiocarbamate inhibits translocation of nuclear factor kappa‐B in neurons and protects against brain ischaemia with a wide therapeutic time window[J]. Journal of Neurochemistry . 2004 (3)
6Eduardo Candelario-Jalil,Armando González-Falcón,Michel Garc??a-Cabrera,Olga Sonia León,Bernd L Fiebich.Wide therapeutic time window for nimesulide neuroprotection in a model of transient focal cerebral ischemia in the rat[J]. Brain Research . 2004 (1)
7Eduardo Candelario-Jalil,Dalia Alvarez,Juana M. Casta?eda,Said M. Al-Dalain,Gregorio Mart??nez-Sánchez,Nelson Merino,Olga Sonia León.The highly selective cyclooxygenase-2 inhibitor DFU is neuroprotective when given several hours after transient cerebral ischemia in gerbils[J]. Brain Research . 2002 (2)
8James A Clemens.Cerebral ischemia: gene activation, neuronal injury, and the protective role of antioxidants[J]. Free Radical Biology and Medicine . 2000 (10)
9Nakayama M,Uchimura K,Zhu R L,et al.Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia. Proceedings of the National Academy of Sciences of the United States of America . 1998
10Hiasa G,Hamada M,Ikeda S,et al.Ischemic preconditioning and lipopolysaccharide attenuate nuclear factor-kappaB activation and gene expression of inflammatory cytokines in the ischemia-reperfused rat heart. Japanese Circulation Journal . 2001
